Pediatric Cataract

Maria Kugelberg

A study in Sweden showed the incidence of all congenital cataract cases to be 36/100,000 (Abrahamsson et al. 1999).
In addition, a few hundred children develop juvenile cataract each year in Sweden. Congenital cataract is considered to be the most common cause of treatable blindness in children.
It is present at birth and may be unnoticed until the visual function is affected or a whitish pupil is seen. If the babies do not have surgery quickly they develop irreversible amblyopia.
Pediatric cataract surgery is nowadays an increasingly safe procedure, although there are some complications to the surgery. Visual axis opacification is the most common complication,
which threatens the vision again and can lead to amblyopia if not managed. Secondary glaucoma is the most feared complication and can lead to blindness and a cosmetically disturbing eye.
Developmental cataract, which is not dense at birth, is more common and could be operated on much later. This would lead to fewer complications and a better outcome.

Congenital cataract

Congenital cataract is hereditary in approximately one third of the cases. It is often inherited
autosomal dominant but can also be inherited autosomal recessive or X-linked. In
approximately one third of the cases other diseases can be found. Metabolic disorders, such as
galactosaemia and hypocalcaemia are rare causes. Intrauterine infections such as rubella,
toxoplasmosis, herpes, varicella and syphilis can cause congenital cataract. Genetic
syndromes such as trisomy 21 or Turner’s syndrome and a variety of neurological disorders
are often associated with congenital cataract. Other ocular anomalies such as iris coloboma,
6 4
aniridia, microphthalmia, retinopathy of prematurity, or persistent foetal vasculature (PFV)
are often combined with cataract. In the rest of the patients, the congenital cataract is
idiopathic. In unilateral cases, the cause is most often idiopathic and in a clinically healthy
child, or if the cataract is inherited, there is no need for an extensive pre-operative evaluation.
5-20% of childhood blindness worldwide is caused by cataracts.
There are different types of cataract; nuclear, lamellar, sutural, polar, lenticonus, membranous
and those associated with PFV. The size, density, laterality of the cataract and the presence of
associated ocular abnormalities decide how strong the indication is for surgery. The more
central and the more posteriorly located, the more visually significant the cataract will be.
Since there are more complications after early surgery as discussed below, it is important to
wait if the cataract is not visually significant.
In cases with dense congenital cataract the cataract surgery must be performed early to
prevent irreversible amblyopia and nystagmus. At the same time the risk of secondary
glaucoma increases in these very small children, the earlier the surgery is performed. It is
therefore very important to find ways to reduce the risk for secondary glaucoma. Also, the
visual axis opacification formation is much more pronounced in the youngest children.
Secondary glaucoma
The earlier the surgery is performed, the greater the risk of secondary glaucoma. The risk also
seems to be greater in small eyes, as in microphthalmus with persistent fetal vessels. It is yet
not clear what causes the secondary glaucoma. However, an IOL seems to decrease the risk.
Arsani et al (Asrani et al. 2000) found a much higher rate of glaucoma following cataract
surgery in patients who were left aphakic (14/124 patients), than if they were implanted with
an IOL (1/377 patients). They also reviewed the literature and found no reported case of openangle
glaucoma in the over one thousand pseudophakic patients from the studies. In one of
our studies, no eye out of 31 children implanted with a small acrylic SA30AL IOL at 2-28
months of age developed secondary glaucoma (Kugelberg et al. 2006). In a rabbit study we
performed with 20 three week old rabbits, no eye implanted with an AcrySof SA30AT IOL
developed secondary glaucoma, but three aphakic eyes did during the follow-up time.
However, in other animal studies with different IOLs the frequency of secondary glaucoma
was similar in aphakic and pseudophakic eyes. It might also be due to the increased
inflammatory response in young children and infants, compared to older children.
6 5
Treatment of postoperative aphakia
Implantation of an IOL is now a common and accepted management of the postoperative
aphakia even in the smallest children. For the very small eye of an infant most of the
commercially available IOLs are too large. The myopic shift that occurs in the child’s
growing eye is also a great concern. Lately, after surgery for unilateral cataract, many
surgeons implant an IOL also in infants. However, for optical correction in bilateral cases
with congenital cataract, contact lenses are probably still most often used in the Western
World. Contact lenses can cause infection, are sometimes hard to handle, tedious for the
family and expensive. Compliance is often also poor regarding the use of contact lenses.
Therefore it would be of great interest if it were possible to develop an IOL that fits the small
eye. We have performed some studies evaluating different smaller lenses in a rabbit model
and in small children. They seem well tolerated by the small eye.
Visual axis opacification
Visual axis opacification or after-cataract occurs when lens epithelial cells (LECs) migrate
and proliferate from the anterior capsule and the equator of the lens capsule, onto the posterior
capsule. The visual axis is then obscured, and vision blurred again. Children develop more
and faster visual axis opacification than adults. This opacification, or posterior capsule
opacification as it is called in adults, can be removed in a second procedure in adults, using
Neodymium: YAG (Nd:YAG) laser. An opening is then created in the posterior capsule, and
the vision is clear again. In most cases, visual axis opacification in children can not be
removed with only Nd:YAG laser, because the LECs will continue to grow on the anterior
vitreous surface. The opacification has preferably to be removed in a second surgical
procedure with anterior vitrectomy, often via the pars plana. However, in the very small
children the LECs can grow also on the posterior surface of the IOL, even after a vitrectomy
is performed.
To diminish visual axis opacification in children, most cataract surgeons perform posterior
capsulorhexis at surgery. It is also debated whether or not to do an anterior vitrectomy at
primary surgery. It could be performed through the pars plana, or through the anterior
chamber after the posterior capsulorhexis and implantation of an IOL. When the anterior
vitreous has been removed, the LECs most often cannot grow on the remaining vitreous. It
6 6
seems that anterior vitrectomy is necessary at least in children below 5 years, to avoid rapid
visual axis opacification.
Another surgical technique that has been studied is a so called optic capture, i.e. the IOL is
pushed through the posterior capsulorhexis, while the haptics remain in the bag. However, the
technique does not seem to fully prevent the formation of visual axis opacification, and it has
been described that the anterior vitreous face became semi-opaque and that the LECs can
grow also on the anterior surface of the IOL. However, optic capture might be a suitable
technique in some instances, since it provides a good centration of the IOL, which is
necessary in cases after trauma or an incomplete rhexis.
Removal of residual LECs during the primary surgery is a key factor in avoiding posterior
capsule opacification. Several chemicals have been suggested in experimental settings to
remove or destroy residual LECs, but it has to be kept in mind that the substances may be
toxic to other ocular structures. Research is directed towards finding a device or substance
that can selectively remove the LECs. There are always complications associated with
touching the vitreous and breaking the posterior lens capsule. If this can be avoided, it would
be highly advantageous. This however, generates the need for a lens capsule with no
remaining LECs. Perhaps a sealed-capsule irrigation could be an option at least in pediatric
Perfect Capsule
The sealed-capsule irrigation device, Perfect Capsule, invented by Anthony Maloof (Agarwal
et al. 2003), consists of a silicone plate, 0.7 mm thick, 7 mm in outer diameter, and 5 mm in
inner diameter. It has an inflow tube, an outflow tube, and a tube for creation of a vacuum.
The device can be folded and introduced through a normal small incision. After the lens
extraction, the device is placed over the anterior capsulorhexis, and a vacuum is created with a
syringe. This produces a sealed system between the capsular bag and the device. The capsule
can be irrigated with a substance through the inflow tube, and the substance does not come in
contact with the other intraocular structures. The substance is washed out with balanced salt
solution (BSS), the vacuum is released, and the device is withdrawn. An IOL then can be
placed in the bag.
6 7
Human studies have reported the safety of the device in adults undergoing cataract surgery. In
that study, the sealed system was irrigated with distilled deionized water, which did not
prevent posterior capsule opacification development. Earlier in vitro studies had shown that
the LECs succumbed from osmotic lysis when they were exposed to distilled deionized water.
However, this evidently did not work in vivo.
We evaluated the Perfect Capsule in a young rabbit model. Our experiments showed that 5-
fluorouracil 50 mg/ml was the most effective substance evaluated to prevent visual axis
opacification (Abdelwahab et al. 2008) (Fig. 1 D). We also investigated a substance called
thapsigargin, which has proven effective in in vitro studies of human LECs, but the substance
was not effective in our model (Fig. 1).
Figure 1. Rabbit eyes that have undergone clear lens extraction and irrigation with different
substances in the sealed-capsule irrigation device Perfect Capsule. Conditions six weeks
postoperativly. (Top left) Eye irrigated with thapsigargin. The eye shows synechia and visual
axis opacification. (Top right) Eye irrigated with BSS; synechia and visual axis opacification
is seen. (Bottom left) Eye irrigated with 5-fluorouracil 25 mg/ml. Some synechia is seen.
(Bottom right) Eye irrigated with 5-fluorouracil 50 mg/ml. A clear visual axis and no
synechia (Abdelwahab et al. 2008).
5-FU 50
5-FU 25
6 8
The safety of 5-FU 50 mg/ml as an irrigation substance with the Perfect Capsule device was
investigated, no damage was seen in the corneal endothelium, trabecular meshwork, and
central and peripheral retina. We did not detect any damage when looking at the posterior
capsule with transmission electron microscopy.
In conclusion, pediatric cataract is still much more problematic than cataract in adults.
However, nowadays, IOLs are implanted at a younger age, less secondary glaucoma is then
seen, and methods are invented to diminish the visual axis opacification. Hopefully, the
research can continue and provide even more information to aid the children in the future.
Abdelwahab MT, Kugelberg M & Zetterstrom C (2008): Irrigation with thapsigargin and
various concentrations of 5-fluorouracil in a sealed-capsule irrigation device in young rabbit
eyes to prevent after-cataract. Eye (Lond) 22: 1508-13.
Abrahamsson M, Magnusson G, Sjostrom A, Popovic Z & Sjostrand J (1999): The
occurrence of congenital cataract in western Sweden. Acta Ophthalmol Scand 77: 578-80.
Agarwal A, Agarwal S & Maloof A (2003): Sealed-capsule irrigation device. J Cataract
Refract Surg 29: 2274-6.
Asrani S, Freedman S, Hasselblad V, et al. (2000): Does primary intraocular lens implantation
prevent “aphakic” glaucoma in children? J Aapos 4: 33-9.
Kugelberg M, Kugelberg U, Bobrova N, Tronina S & Zetterstrom C (2006): Implantation of
single-piece foldable acrylic IOLs in small children in the Ukraine. Acta Ophthalmol Scand
84: 380-3.


Ovanstående är ett utdrag ur:

Advances in Pediatric Ophthalmology Research. Gunnar Lennerstrand and Gustaf Öqvist Seimyr, Eds. The Sigvard & Marianne Bernadotte Research Foundation for Children Eye Care. Stockholm, 2010.

Utgiven med anledning av Stiftelsens 20-års jubileum.

Copyright 2023 © All rights Reserved. Hemsida Webbdesign Interwebsite Webbyrå